2005
DOI: 10.1016/j.gyobfe.2005.03.004
|View full text |Cite
|
Sign up to set email alerts
|

Hystéroscopie diagnostique et risque de contamination péritonéale par les cellules tumorales

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2009
2009
2021
2021

Publication Types

Select...
3
3

Relationship

0
6

Authors

Journals

citations
Cited by 22 publications
(2 citation statements)
references
References 25 publications
0
2
0
Order By: Relevance
“…However, in case of sarcoma the oncological effect of minimal amounts of spread or leakage, henceforth called micro-spillage, into the abdominal cavity is unclear. For instance, in endometrial carcinoma the spread of malignant cells in the abdominal cavity via the fallopian tubes during hysteroscopy does not appear to negatively influence clinical outcome [ 10 12 ]. The same might apply to our findings.…”
Section: Discussionmentioning
confidence: 99%
“…However, in case of sarcoma the oncological effect of minimal amounts of spread or leakage, henceforth called micro-spillage, into the abdominal cavity is unclear. For instance, in endometrial carcinoma the spread of malignant cells in the abdominal cavity via the fallopian tubes during hysteroscopy does not appear to negatively influence clinical outcome [ 10 12 ]. The same might apply to our findings.…”
Section: Discussionmentioning
confidence: 99%
“…However, in high risk populations for endometrial cancer, such as patients undergoing Tamoxifen theraphy, its recomended to use biopsy and hysteroscopic evaluation in combination ( 13 ) . Although its assumed that hysteroscopic examination in high risk patients for cancer, may increase the risk of dissemination of malignant cells into the peritoneal cavity, in recent meta-analyse no evidence was found to support an association between hysteroscopic examination and peritoneal cytology ( 14 ) .…”
Section: Discussionmentioning
confidence: 99%